Head-to-head · WeighScore
Mint Med vs AgelessRx
The verdict
Too close to call — both grade 84/100 (B).
Mint Med and AgelessRx land on the same WeighScore, so neither clears the other on our six graded dimensions. AgelessRx sits one line higher on the board (#11 vs #15) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
Partner links are labeled — we may earn a commission at no cost to you. It never changes the grade.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mint Med | AgelessRx |
|---|---|---|
| WeighScore | 84/100 | 84/100 |
| Grade | B | B |
| Scorecard rank | #15 | #11 |
| Semaglutide | $117/mo | $139/mo |
| Tirzepatide | $159/mo | Not disclosed |
| Coverage | 36 states | Not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
| Relationship | Editorial | Partner |
Graded #15 · B
Strengths
- $117 sema / $159 tirz
- LegitScript-verified
- Both molecules
Where it loses points
- Only 36 states
- Injection-only
- Monitoring detail sparse
Graded #11 · B
Strengths
- Low-end semaglutide pricing
- Some brand-name access
- Established brand
Where it loses points
- Tirzepatide pricing not disclosed
- States not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 25 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.